353810 — Easy Bio Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesAdventurousSmall CapSuper Stock

Annual income statement for Easy Bio, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	129,458	155,557	165,385	384,331	476,939
Cost of Revenue
Gross Profit	40,631	47,283	52,018	98,478	121,044
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	112,678	139,404	144,754	354,180	431,949
Operating Profit	16,779	16,153	20,631	30,151	44,990
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	14,054	11,984	20,066	26,376	38,657
Provision for Income Taxes
Net Income After Taxes	10,842	9,347	16,101	19,904	29,272
Minority Interest
Net Income Before Extraordinary Items
Net Income	10,873	9,131	15,544	19,604	27,778
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	10,873	9,131	15,544	19,604	27,778
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	318	267	455	632	840
Dividends per Share